HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
暂无分享,去创建一个
D. Blaise | A. Moine | A. Toubert | R. Tamouza | M. Busson | D. Charron | L. Absi | K. Gagne | J. Jouet | V. Dubois | V. Lepage | C. Raffoux | L. Gebuhrer | P. Loiseau | D. Reviron | J. Bignon | M. Balère | A. Dormoy | I. Jollet | M. Bois | P. Perrier | D. Masson | É. Marry | Z. Chir
[1] D. Gjertson,et al. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans , 2006, Immunogenetics.
[2] A. Toubert,et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders , 2006, Bone Marrow Transplantation.
[3] F. Christiansen,et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] A. Gratwohl,et al. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland , 2006, Bone Marrow Transplantation.
[5] C. Carcassi,et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. , 2006, Blood.
[6] N. Russell,et al. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. , 2006, Blood.
[7] J. Partanen,et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. , 2005, Tissue antigens.
[8] M. Horowitz,et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. , 2005, Blood.
[9] Effie W Petersdorf,et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. , 2004, Blood.
[10] Harriet Noreen,et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.
[11] Marcos González,et al. HLA-DPB1 MISMATCH IN HLA-A-B-DRB1 IDENTICAL SIBLING DONOR STEM CELL TRANSPLANTATION AND ACUTE GRAFT-VERSUS-HOST DISEASE , 2004, Transplantation.
[12] R. Handgretinger,et al. Determinants of Antileukemia Effects of Allogeneic NK Cells 1 , 2004, The Journal of Immunology.
[13] Maria Pia Sormani,et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. , 2003, Blood.
[14] J. Cazenave,et al. Mono-allelic amplification of exons 2-4 using allele group-specific primers for sequence-based typing (SBT) of the HLA-A, -B and -C genes: preparation and validation of ready-to-use pre-SBT mini-kits. , 2003, Tissue antigens.
[15] James McCluskey,et al. A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition , 2003, The Journal of experimental medicine.
[16] Franco Locatelli,et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.
[17] J. Madrigal,et al. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.
[18] K. Hsu,et al. The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.
[19] R. Tamouza,et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation , 2002, Bone Marrow Transplantation.
[20] H. Inoko,et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.
[21] E Lanino,et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.
[22] A. Tosti,et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.
[23] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[24] J. McCluskey,et al. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. , 1999, Human immunology.
[25] Takato O. Yoshida,et al. EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .
[26] G. Longton,et al. Definition of HLA-DQ as a transplantation antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.